Human Health Holdings Limited (HKG:1419)
0.7650
+0.0050 (0.66%)
Oct 14, 2026, 3:50 PM HKT
Human Health Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 290 | 277 | 315 | 387 | 721 | 619 | |
Market Cap Growth | -12.07% | -12.05% | -18.63% | -46.32% | 16.56% | 63.00% |
Enterprise Value | -100 | -77 | -33 | 63 | 358 | 412 |
Last Close Price | 0.76 | 0.73 | 0.80 | 0.95 | 1.57 | 1.13 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 10.70 | 10.21 | 11.96 | 16.01 | 3.99 | 1.65 |
Forward PE | - | 18.97 | 18.97 | 18.97 | 18.97 | 18.97 |
PS Ratio | 0.43 | 0.41 | 0.49 | 0.66 | 0.72 | 0.55 |
PB Ratio | 0.36 | 0.35 | 0.40 | 0.51 | 0.89 | 0.83 |
P/TBV Ratio | 0.40 | 0.39 | 0.45 | 0.53 | 0.93 | 0.88 |
P/FCF Ratio | - | - | 3.47 | - | 1.24 | 2.82 |
P/OCF Ratio | - | - | 3.20 | 29.32 | 1.09 | 2.09 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | - | - | - | 0.11 | 0.36 | 0.37 |
EV/EBITDA Ratio | - | - | - | 1.61 | 1.11 | 0.94 |
EV/EBIT Ratio | - | - | - | 3.47 | 1.17 | 0.96 |
EV/FCF Ratio | - | - | - | - | 0.62 | 1.88 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.17 | 0.19 | 0.23 | 0.25 |
Debt / EBITDA Ratio | 2.24 | 2.24 | 1.37 | 1.70 | 0.48 | 0.38 |
Debt / FCF Ratio | - | - | 1.48 | - | 0.32 | 0.86 |
Net Debt / Equity Ratio | -0.49 | -0.49 | -0.39 | -0.45 | -0.57 | -0.11 |
Net Debt / EBITDA Ratio | -6.55 | -6.55 | -6.03 | -8.78 | -1.42 | -0.19 |
Net Debt / FCF Ratio | - | - | -3.36 | 13.05 | -0.79 | -0.37 |
Asset Turnover | 0.63 | 0.63 | 0.61 | 0.51 | 0.83 | 1.27 |
Inventory Turnover | 16.39 | 16.39 | 12.17 | 10.59 | 17.51 | 28.62 |
Quick Ratio | 2.77 | 2.77 | 2.57 | 2.58 | 2.13 | 2.30 |
Current Ratio | 3.03 | 3.03 | 2.89 | 2.84 | 2.28 | 2.43 |
Return on Equity (ROE) | 3.60% | 3.60% | 3.44% | 3.07% | 23.33% | 65.15% |
Return on Assets (ROA) | 2.30% | 2.30% | 1.78% | 0.98% | 15.85% | 30.27% |
Return on Invested Capital (ROIC) | 8.83% | 8.11% | 5.99% | 4.28% | 46.07% | 74.18% |
Return on Capital Employed (ROCE) | 4.60% | 4.60% | 3.50% | 2.20% | 33.60% | 50.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 9.40% | 9.79% | 8.36% | 6.25% | 25.08% | 60.66% |
FCF Yield | - | - | 28.83% | -6.79% | 80.46% | 35.45% |
Dividend Yield | 4.05% | 4.25% | 3.61% | 2.74% | 8.42% | 18.40% |
Payout Ratio | - | - | 40.35% | 251.06% | 62.96% | 12.14% |
Total Shareholder Return | 4.05% | 4.25% | 3.61% | 2.74% | 8.42% | 18.40% |